|
1
|
|
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
(nature.com)
|
Yu M
…
Xiao X
Nature Medicine
2026-09-29
|
#diabetes
#clinical trial
#glp-1 agonist
#pharmacotherapy
#glycemic control
|
|
1
|
|
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Bellido V
…
Taylor A
The Lancet
2026-09-29
|
#clinical trial
#diabetes
#obesity
#pharmacotherapy
|
|
0
|
|
GLP-1 receptor agonist exposure in the periconceptional period and adverse obstetric outcomes: A systematic review and meta-analysis.
(linkinghub.elsevier.com)
|
D'Antonio F
…
Khalil A
Cell Med
2026-09-29
|
#meta-analysis
#pregnancy
#pharmacology
#obstetrics
#diabetes
|
|
1
|
|
Microbial aldehyde-alcohol dehydrogenase degrades metformin to limit therapeutic response in type 2 diabetes.
(linkinghub.elsevier.com)
|
Zhao Y
…
Wang T
Cell Metabolism
2026-09-29
|
#microbiome
#diabetes
#pharmacokinetics
#metabolism
#enzyme
|